🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open label, randomized study of durvalumab in combinati...
Status
Terminated
Location
Huntsman Cancer Institute at University of Utah
Start Date
2020-06-18
Trial ID
NCT04163432
Treatments Being Tested
This is a single-center, randomized, partially double-blind, placebo and ac...
Status
Completed
Location
California Clinical Trials Medical Group, Inc.
Start Date
2024-09-25
Trial ID
NCT06591845
Treatments Being Tested
This is a prospective, multi-center study of patients with intracranial or ...
Status
Completed
Location
Hoag Hospital
Start Date
2011-11
Trial ID
NCT01465841
Treatments Being Tested
This study is a prospective, multi-center registry of patients with intracr...
Status
Completed
Location
CHU Pellegrin
Start Date
2013-01
Trial ID
NCT01754051
Treatments Being Tested
To evaluate whether pregabalin and/or celecoxib could improve analgesic eff...
Status
Completed
Location
Supranee Niruthisard
Start Date
2008-07
Trial ID
NCT01344213
Treatments Being Tested
This is a single-armed, single-centre, non-blinded phase II trial to assess...
Status
Recruiting
Location
UZ Leuven
Start Date
2024-08-13
Trial ID
NCT06353906
This is an open, non-randomized, phase I-II, pilot study, which evaluates t...
Status
Completed
Location
Service de Chirurgie Générale et Thoracique, Centre Hospitalier Lyon-Sud
Start Date
2007-06
Trial ID
NCT01226550
Treatments Being Tested
Mulberry leaf teas or extracts are used as a natural remedy for diabetes in...
Status
Completed
Location
Hope Medical Clinic
Start Date
2011-09
Trial ID
NCT01305434
Treatments Being Tested
This study combines canakinumab (ACZ885), a high-affinity human anti-interl...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-11-02
Trial ID
NCT04581343
Treatments Being Tested
The study is a Phase I, Single center, Randomized, Cross-over Double-blind ...
Status
Completed
Location
Clinical Pharmacology unit, SGS-Life Science Service
Start Date
2017-08-21
Trial ID
NCT03657264
Treatments Being Tested